ZEISS Receives FDA Clearance for Epithelial Thickness Mapping for CIRRUS HD-OCT, Enabling More Detailed Assessment of Refractive Surgery Patients

Contact for the press
Laurie Ferguson Head of OPT Global Communications Carl Zeiss Meditec Inc. Phone: +1 925 560 5163 press.meditec@zeiss.com
Contact for investors
Sebastian Frericks
Director Investor Relations Carl Zeiss Meditec AG
Phone: +49 3641 220-116
Email:?investors.meditec@zeiss.com